Holen Sie sich die Stockscreener-App
2.075
3.94%
-0.085
Finanzdaten der Inmune Bio Inc-Aktie (INMB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
100.00%
-
|
0.05 | - | - | - |
Operating Expenses
|
146.82%
24.57
|
9.955 | 9.467 | 12.29 | 9.865 |
| Benefits Costs and Expenses |
-
|
- | -42.07 | - | - |
| Costs And Expenses |
146.82%
24.57
|
9.955 | -75.25 | 12.29 | 9.865 |
| Operating Income/Loss |
148.07%
-24.57
|
-9.905 | -9.467 | -12.29 | -9.865 |
| Nonoperating Income/Loss |
31.93%
0.113
|
0.166 | 0.249 | 0.193 | - |
| Income/Loss From Continuing Operations Before Tax |
151.13%
-24.46
|
-9.739 | 42.07 | -12.09 | -9.746 |
| Income/Loss From Continuing Operations After Tax |
151.13%
-24.46
|
-9.739 | 74.95 | -12.09 | -9.746 |
|
Net Income/Loss
|
151.13%
-24.46
|
-9.739 | -9.218 | -12.09 | -9.746 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3.57%
23.30
|
22.50 | 0.7675 | 20.19 | 19.31 |
| Diluted Average Shares |
3.57%
23.30
|
22.50 | 0.7675 | 20.19 | 19.31 |
| Basic Earnings Per Share |
144.19%
-1.05
|
-0.43 | -0.40 | -0.60 | -0.50 |
| Diluted Earnings Per Share |
144.19%
-1.05
|
-0.43 | -0.40 | -0.60 | -0.50 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.88%
7.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):